A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions
Journal of Attention Disorders · 2025-06 · 29 (8) · 602-616
DOI: 10.1177/10870547251315601 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Attention Disorders, online erschienen am 29.01.2025. Verfasst von Iris L Rapoport und 1 weiteren Autor:innen. Beteiligte Einrichtung: University of Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 135 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: universiteit van amsterdam.
Abstract (Originalsprache)
Objective
Stimulant medications are the primary pharmacological intervention for ADHD, yet our understanding of how sex and gender impact stimulant treatment outcomes remains limited. Clinical guidelines do not differ for female and male individuals despite possible sex and gender-related differences in effectiveness, adverse events, and pharmacokinetics. This theoretical framework identifies five key knowledge gaps relating to sex and gender effects in stimulant treatment.
Method
We investigate the stimulant treatment trajectories of girls and women with ADHD from diagnosis and prescription to daily use and outcomes. We examine the impact of reproductive life transitions and hormonal fluctuations and their interactions with gender socialization and gendered expectations on treatment effectiveness, stigma, and adherence.
Results
By synthesizing existing literature, proposing testable predictions, and suggesting future research directions, we highlight the urgent need for studies that systematically investigate these factors.
Conclusion
Addressing these gaps could significantly improve treatment outcomes for girls and women with ADHD, particularly during biological and gender role transitions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Amsterdam, The Netherlands.
- University of Groningen, The Netherlands.
- Accare Child Study Center, Groningen, The Netherlands.
ORCID-Profile: Iris L Rapoport, Annabeth P Groenman
Förderung
- universiteit van amsterdam
Zitieren
APA
Rapoport, I. L., & Groenman, A. P. (2025). A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions. Journal of Attention Disorders, 29(8), 602-616. https://doi.org/10.1177/10870547251315601
Vancouver
Rapoport IL, Groenman AP. A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions. Journal of Attention Disorders. 2025;29(8):602-616. doi:10.1177/10870547251315601
BibTeX
@article{Rapoport2025,
author = {Rapoport, Iris L and Groenman, Annabeth P},
title = {A Review of Sex and Gender Factors in Stimulant Treatment for ADHD: Knowledge Gaps and Future Directions},
journal = {Journal of Attention Disorders},
year = {2025},
volume = {29},
number = {8},
pages = {602--616},
doi = {10.1177/10870547251315601}
}
EUVIMED